Loading insider details...
Latest Form 4 (Jun 1, 2026): Exercise/Conversion of 2,010 ACAD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 2,010 | n/a |
| Mar 20, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 7,482 | n/a |
| Jan 30, 2020 | Evelo Biosciences, Inc. (EVLO) | Grant/Award | 106,000 | n/a |